NCT04176614 is a NA clinical trial of cereal-legume snack in Overweight and Obesity, sponsored by Harokopio University.

Who is sponsoring NCT04176614?

NCT04176614 is sponsored by Harokopio University.

What drugs are being tested in NCT04176614?

Interventions in NCT04176614: cereal-legume snack, cereal snack.

What condition does NCT04176614 study?

NCT04176614 studies Overweight and Obesity.

Is NCT04176614 still recruiting?

NCT04176614 is currently completed. Last updated 14 February 2022.

Last reviewed 2022-02-14 · How we verify

NCT04176614

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cereal-based Products Fortified With Legumes and Effects on Body Weight Management

Completed NA Last updated 14 February 2022

What this trial tests

NA trial testing cereal-legume snack in Overweight and Obesity in 70 participants. Completed in 25 March 2021.

Timeline

20 January 2020

Primary endpoint
25 March 2021

25 March 2021

Quick facts

Lead sponsor	Harokopio University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	70
Start date	20 January 2020
Primary completion	25 March 2021
Estimated completion	25 March 2021
Sites	1 location across Greece

Drugs / interventions tested

cereal-legume snack
cereal snack

Conditions studied

Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

Harokopio University

Who can join

Adults 18 to 60, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Legumes are high nutritional quality foods and constitute a rich source of proteins and dietary fibers which have been associated with appetite regulation and body weight management. The purpose of the study is to investigate the effects of regular consumption of a cereal-based snack fortified with legumes on body weight reduction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Wheat Biscuits Enriched with Plant-Based Protein Contribute to Weight Loss and Beneficial Metabolic Effects in Subjects with Overweight/Obesity.
Binou P, Yanni AE, Kartsioti K, Barmpagianni A, et al · · 2022 · cited 6× · PMID 35745249 · DOI 10.3390/nu14122516

Verify or expand the search:

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other Harokopio University trials

Trials by the same sponsor.

NCT06997510 — Better4All Personalized Intervention · NA · not yet recruiting
NCT07233707 — Load and Hold: Impact of 7-Day Creatine Monohydrate Loading on Breath-Hold Cycling Performance · NA · enrolling by invitation
NCT07505680 — Time-restricted Feeding and Health · NA · completed
NCT07120802 — Better4All Personalized Intervention Pilot Study · NA · recruiting
NCT07190066 — MELIORA Data Collection Campaigns · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04176614 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Harokopio University
Last refreshed: 14 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04176614.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing